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One of the roost non-specific and often misleading  effects of cortisone as a 
therapeutic agent is its ability to suppress fever. That  it functions as a potent 
antipyretic has been clearly established  (1,  2).  The manner  in which  it  influ- 
ences the febrile  response  to  disease,  however,  is  unknown.  The  studies  re- 
ported in this paper  deal  with  its  action on fever  induced experimentally by 
means of bacterial pyrogens. 
The pattern of fever resulting in any individual species from the intravenous injec- 
tion of most bacterial pyrogens is surprisingly constant (3-5). A highly reproducible 
feature is the latent period of from 15 to 30 minutes# which has led investigators to 
doubt that the fever is due to a direct action of the pyrogen (3). A second characteristic 
is the occurrence of a transient, but often pronounced, leucopenia during the period of 
latency. This leucocytic reaction is demonstrable only when sufficient doses of pyrogen 
are injected (5-8). The thesis has been advanced, but not yet proved, that the phenom- 
ena of fever and lencopenia are causally related  through the release of a  secondary 
endogenous pyrogen from leucocytes trapped or destroyed in the blood vessels  as a 
consequence of the original injection (9). Evidence has also be presented, particularly 
by Grant (10),  that the bacterial pyrogen itself may not initiate the febrile response, 
but that its effect may depend upon its combining with a  factor present in normal 
serum. This "serum factor" has been shown to reside in the a  or fl globulin fraction 
(11,  12) and is lacking in the blood of animals made fever-tolerant by repeated injec- 
tions of the pyrogen (13). 2 Finally, it is well established  that the actual rise in body 
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1  In man the latent period is somewhat longer and usually varies from 45 to 90 minutes (5). 
This factor is hereafter referred to as the serum factor to indicate that its chemical identity 
is unknown and that it may involve the presence of more than a single substance. Recently 
Farr et a/. (11) have shown that the apparent  absence of this factor in tolerant  animals may 
be due to serum inhibitors. The presence of augmenting factors may be demonstrated  in tol- 
erant  serum if it is incubated with a large dose of pyrogen. 
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temperature depends upon  the action of the autonomic nervous system under  the 
control of thermoregulatory centers in the brain (14-20). Whether these centers are 
acted upon  by the pyrogen-serum factor  complex, or by a  secondary endogenous 
pyrogen arising from injured or otherwise affected cells within the vascular system, is 
at present unknown. 
Based on the existing knowledge of pyrogen-induced fever, there appear to be 
at  least  three  possible ways in  which  cortisone  may  act  in  suppressing  the 
febrile response. First, through its well known anti-inflammatory action (21-26) 
it may interfere with the prefever leucopenia, which is said to result from an 
intravascular inflammatory response involving the "sticking" of leucocytes to 
vascular endothelium  (27-30).  Secondly, it may alter the composition of the 
recipient's serum in such a way as to modify the effect of the serum factor upon 
which  the action of the injected pyrogen appears to depend. As regards this 
possibility, cortisone treatment is known to exert an effect upon both the lipid 
(31) and protein (32, 33)  constituents of serum. Or thirdly, cortisone may act 
upon  neither  of the  two  above mechanisms  but  rather  may  influence  some 
later stage of the fever-producing sequence,  involving possibly the release or 
activity of  endogenous  pyrogen  from  intravascular  cells or  the  response  of 
thermoregulatory centers to the pyrogenic stimulus. The results of the present 
studies appear to eliminate conclusively the first two possibilities and thus by 
exclusion support  the  third. 
I.  The E~ect of Cortisone upon  Pyrogen-Induced Fe~er and Leucopenia 
The pyrogens used in these experimenst were: (a)  pyromen, a highly purified  polysaccha- 
ride from a  Pseudomonas species  3 and (b) native dextra,, complex polysaccharide lot N-316, 
with average molecular weight of between  200,000 and 300,000 by viscosity measurement. 4 
In preliminary tests with both pyrogens,  doses were determined which would give a brisk 
fever of 1 to 2°F. in untreated rabbits but which could be blocked by prior treatment with 
cortisone. 5 The latter was injected intramuscularly in an amount of 25 rag. twice a day for 3 
days preceding the experiment, and an additional injection of 25 rag. was given on the morn- 
ing of the experiment.  On this basis, the most satisfactory pyrogenic dose of pyromen was 
found to be 5 gamma per kg., whereas that of dextran was 200 rag. given, regardless of weight, 
in a concentration of 25 rag. per ml. of pyrogen-free saline. 
Rabbits were of albino Flemish and New Zealand stock,  males of 2.5 to 3.5 kg. and ap- 
proximately 4 to 6 months of age. All studies were performed in an air-conditioned room 
(68--70OF.). Each rabbit was placed in a closed box with an opening for the head and was 
given neither food nor water during the test period. Temperatures were recorded by means 
of indoor-outdoor model air guide thermometers, s The cartridge for recording outdoor tern- 
8 Obtained from Baxter Laboratories, Inc., and supplied in vials containing 10 gamma per 
ml. of isotonic solution of sodium chloride. 
4 Kindly supplied by Commercial Solvents Corporation in same lot number as that used 
by Bennett (34) and found to be free of contaminating bacterial pyrogens. 
6 Cortone  (cortisone acetate), furnished  through the courtesy of Merck and Company. 
8 Manufactured by Fee and Stemwedel, Inc., Chicago. All thermometers were carefully 
calibrated over the range of 98 to 106°F., and it was found that they could be read accurately 
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perature was inserted, with a short adjacent length of coiled sleeve, into the rabbit's rectum. 
Readings were begun I  hour after insertion of the recording cartridge and experiments were 
started after a variable period of 30 to 60 minutes of readings to establish a base Hne. Control 
temperatures were measured over periods of 6 or 7 hours on each of the 3 days prior to an 
experiment, and all rabbits exhibiting variations of more than I*F. during the last two control 
periods, or initial temperatures of more than I03°F. on the day of experiment, were discarded. 
Only rarely under these conditions were instances of "emotional hypothermia" (35) encoun- 
tered. Duringeachexperiment  readingswere taken at 10 to 15 minute intervals for the first I~ 
hours following the injection of the pyrogen into the marginal ear vein. In several experiments 
readings were taken every 5 minutes to establish the duration of the latent period with greater 
accuracy. Thereafter, temperatures were recorded every 30 minutes for a  total of 5~  to 6~ 
hours.  Glassware and needles were sterilized by dry heat at  170°C.  for 2 hours in order to 
inactivate contaminating pyrogens (3, 5). Physiological salt solution used as diluent was made 
with doubly distilled water in pyrogen-free glassware and after being autoclaved was tested at 
intervals for pyrogenicity. 
White blood cell counts were made on free flowing blood obtained from the marginal vein 
of the ear opposite the one used for injection of the pyrogen. Preliminary counts were made 
after each rabbit had been confined to its box for about I hour. Two successive counts obtained 
within a  10 minute period and exhibiting a difference of less than 2000 cells were averaged as 
a  preineculstion figure from which subsequent variations after inoculation were calculated. 
Rabbits with pre|imlnary counts of less than 5000 or more than 20,000 were eliminated. Count- 
ing was done with Trenner (N.B.S.)  automatic pipettes and Spencer Bright-line chambers 
utilizing the four corner squares. 
Experiment A.--In the experiment with pyromen, 10 rabbits were pretreated 
with cortisone, as described above, and 10 were left untreated as controls. The 
composite febrile and leucocytic responses of the two groups to the pyromen 
challenge are shown in Fig. 1, and the abridged data on the individual rabbits 
are recorded in Table I. It will be noted that the mean temperature response to 
pyromen was effectively blocked (maximum rise,  <  0.5°F.) by the cortisone, 
whereas the per cent drop in white count, although averaging somewhat less in 
the cortisone-treated animals, did not differ by a statistically significant amount 
(t--  1.24). 
Experiment B.--An even more conclusive dissociation of the febrile and leuco- 
penic responses was observed in an analogous experiment with dextran. As 
shown in Fig. 2 the average temperature response of 7 untreated rabbits  to 
dextran was somewhat greater than that caused by the pyromen and differed 
from the latter in that a secondary rise in temperature occurred at about 21/~ 
hours.  This double-humped pattern  resembles that  reported  with relatively 
large doses of other bacterial pyrogens (e.g., typhoid and coli vaccines) (3, 4, 
I0).  In 7 rabbits pretreated with cortisone the fever was almost  completely 
blocked (< 0.3°F.). But again the fall in white count was essentiaUy the same 
in both the cortisone and control groups. (For more complete data, see Table 
II). 
In summary, it can be stated that, whereas the febrile response in normal 
rabbits  was  regularly associated  with  an  early leucopenia,  treatment  with 
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influencing  the decrease in white ceUsL It is evident,  therefore,  that the anti- 
pyretic effect of cortisone is not due to a blocking of the leucocytic reaction to 
the injected pyrogen. 
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Tzx~-FIO.  I.  Mean deviation  of  temperature  and total  leucocyte  count  of  I0  normal  and 
i0  cortisone-treated  rabbits  after  inoculation  with  pyromen (5  gamma per  kg.). 
TABLE  I 
The Leucocyt~ and Febrile Responses  of 2Vormal (A) and Cortisone-Treated  (B) Rabbi~s 
to Intm,  enous Injection of Pyrorasn, 5 Gamma per Kg 
Animal No. 
Mean  preinoculation leucocyte 
count  ~ 
Maximum rise in  temperature* 
(~  .) 
Maximum  fail  in  leucocytest 
(per cent of mean initial count) 
1 
A  8,78: 
B  }10,832 
 110+ 
A]  4-3 
B~  27  I 
2  3 
6,62  ,87: 
10,61  ,33; 
1.5  2.0 
0  0 
9  0 
53  25 
,Is° 
n,625/11,  82sl9,  71 
12,2251 7,575i9, 6' 
1.o  /  2.5 l 1.: 
o  t.01  o. 
t 
82  82  I 43 
132  45  136 
7  8  I  9  t  10 
19, 0SI  16, 650 10, 325 ll, 70~ 
12,87!  12,1751 9,775'12,972 
2.0  2.0]  1.0  2.0 
2.0  0.5  1.0  0.5  } 
81  53  I  30  62 
65  27  I  49  39 
values 
11,223 
10,406 
1.7 
0.6 
49 
40 
* Average of 2 to 3 successive counts within range of 2000 cells and 15 per cent of mean value. 
During the first 3 hours after lnieetion. 
7 This same observation has recently been reported by Bennett and Beeson (36) in a study 
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TExT-FIo. 2. Mean deviation of temperature and total leucocyte count of 7 normal and 7 
cortisone-treated rabbits after intravenous injection of crude dextran (200 rag.). 
TABLE II 
Tke Leucocyti¢ and Febrile Responses of Normal (A ) and Cortisone-Treated (B) 
Rabbits to Intravenous Injection of Dextran, gO0 Mg. 
Animal No. 
Mean  preinoculation  leu- 
cocyte count* 
Maximum  rise  in  tempera- 
ture~ (°F.) 
Maximum fall in leucocytes:~ 
(per  cent  of  mean  initial 
count) 
1  i  ~ 
A  7,550 8,075 
B  10,6509,45C 
A  4.5  3.0 
I  B  0.5  0 
A  64  66 
B  85  89 
_L 
10, 55 
7,30 
3.0 
1.0 
83 
81 
4 
7,77, 
12,02~ 
3.5 
0.5 
76 
94 
5  6 
10,000  7,72, 
7,625 11,75q 
2.5  [  2.0 
1.5  0 
[ Mean 
valu____~ 
17,425  9,8?0 
6,625 9,345 
2.5  3.0 
0.5  0.6 
93  69 
77  86 
* Average of 2 to 3 counts within range of 2000 cells and  15 per cent of mean value. 
:~ During the first 5 hours after injection. 
H.  The  Effect  of Cortisone  upon  the  Serum  Factor of Pyrogen-Induced  Fever 
That  a  serum  factor  is  involved in  pyrogen-induced  fever has  been  conclusively 
demonstrated.  First, it has been shown by Farr and LeQuire (8, 37-39) and by Grant 358  ANTIPYRETIC  ACTION  O~  CORTISONE 
(10, 40) that previous incubation of the pyrogen in normal rabbit serum, plasma, or 
whole blood hastens the febrile response of recipient rabbits. According to the former 
workers, the height and duration of the fever is also increased.  Secondly,  Grant (13) 
has observed that pyrogen tolerance may be partially reversed by previous incubation 
of the  challenging  dose with normal serum. The response of the pyrogen-tolerant 
rabbit differs from that of the normal by virtue of a marked prolongation of the pre- 
fever latent period and a pronounced decrease in the height and duration of the fever. 
That this altered response of the tolerant animal involves, at least in part, a change in 
one or more factors normally contained in the serum, is evident from Grant's observa- 
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TExT-FIo. 3. Potentiation of the febrile response of a pyrogen-tolerant rabbit by injection 
of 75 million typhoid bacilli incubated in 5 ml. of normal homologous serum. Responses to the 
same dosage of vaccine in pyrogen-free saline, given on the 3 preceding days, are shown for 
comparison. 
tion that the prolonged latency may be completely reversed and the degree of febrile 
response partly restored by merely incubating the pyrogen with normal rabbit serum 
before injection;  whereas incubation of the pyrogen with serum from a tolerant animal 
has no such effect. Data confirming both of these latter Observations are presented in 
Figs. 3 and 4  (see below). 
In the present studies  two experiments were performed to investigate the 
possible effect of cortisone upon the serum factor. They were based upon the 
following reasoning. If cortisone acts as an antipyretic by affecting the serum 
factor, it should be possible to demonstrate:  (1) a  depression of serum factor 
activity in the blood of cortisone-treated rabbits and (2) a failure of cortisone 
to suppress fever induced by pyrogen previously exposed to the active "factor." 
These two possibilities were tested. In the first experiment, pyrogen, which had 
been incubated with serum from cortisone-treated rabbits,  was injected into E. ATEINS, F. ALLISON, JR.,  M. R. SMITH, W.  B. WOOD, J~.  359 
pyrogen-tolerant  recipients.  In  the  second,  cortisone-treated  rabbits  were 
challenged  with pyrogen incubated  in normal  serum prior  to injection. 
The  methods  and  materials  used  in  these  experiments  have  already  been 
described above except for the following. 
1..Pyrogen. The pyrogen used was typhoid vaccine, monovalent reference standard NRV-LS 
No. I, made from Salmonella typhosa V-58. s 
2.  Pyrogen tolerate was established by daily intravenous injections of a uniform  dose of 
75 million organisms (calculated as approximately 25 million per kg.), The temperature re- 
sponse was recorded on the 1st day to insure that all animals included were "reactors." It was 
J  --  : typhoid-saline  suspension 
c  :typhoid  suspension  in serum  from 
~  pyrogen-toleront  donors 
~ 
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TzxT-FIo. 4. Lack of potentiation of the febrile response of a pyrogen-tolerant rabbit in- 
oculated with 75 million typhoid bacilli incubated with 5 ml. of serum from pyrogen-tolerant 
donors. Responses to the same dosage of  vaccine in pyrogen-free saline,  given on the 3 pre- 
ceding days, are shown for comparison. 
then not remeasured until after the 10th day of injections, but was recorded again on the 3 
successive days preceding the experiment,  in  order to make certain  that  tolerance to  the 
pyrogen had been established. 
3.  Collection  ofsera. Each sample of serum used was composed of a pool from 2 or 3 animals. 
Serum was obtained by cardiac puncture from (a) normal rabbits, (b) pyrogen-tolerant rabbits, 
and (0 rabbits treated for 3 successive days with cortisone as described above. The sera were 
stored at 4°C. and in most experiments were used within 2 or 3 days. All samples were checked 
for sterility. 
4.  Incubation of pyrogen-sergm miztures.  Each typhoid vacdne-serum mixture  (except as 
otherwise indicated in Experiment E) was made up to contain 75 million organisms per 5 or 
10 ml. of serum and was stored in the ice box for 16 to 18 hours. Before injection the mixture 
s Secured through the courtesy of Dr. Geoffrey Edsall of the Army Medical Service Gradu- 
ate School, Walter Reed Army Medical Center, Washington, D. C. This vaccine had a  bac- 
teriai count of approximately 500 million per mL and a nitrogen content of 0.03 rag. per ml. 
(-4-10 per cent). 360  ANTIPYRETIC  ACTION  OF  CORTISONE 
was incubated at 37°C. for 1 hour during which time it was shaken frequently to insure ade- 
quate mixing. The volume injected into each rabbit (either 5 or 10 ml.) contained the standard 
pyrogenic dose of 75 million organisms. 
Experiment C.--A  preliminary  experiment  was  first  performed  in  which 
tolerant rabbits were challenged with vaccine incubated in both normal and 
"refractory" serum.  9 Representative results are shown in Figs 3 and 4. After 
approximately 10 daily injections of pyrogen in each experiment, tolerance was 
manifested by a  lengthened latent period,  elimination of the  second febrile 
peak and a  moderate reduction in the initial temperature rise. Following in- 
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TExT-FIo.  5. Potentiation of the febrile response of a pyrogen-tolerant  rabbit by injection 
of 75 million typhoid bacilli incubated in 5 ml. of serum from cortisone-treated  rabbits. Re- 
sponses to the same dosage of vaccine in pyrogen-free  saline, given on the 3 preceding days, 
are shown for comparison. 
jection of the same dose of vaccine incubated in 5 ml. of normal ("non-refrac- 
tory") serum, there was a marked and consistent shortening of the htent period. 
If the latent period is defined as the elapsed time between the injection and the 
first  reading  of  I°F.  above  the  last preinoculation  temperature,  the  latent 
periods in the tolerant control observations (21 instances) varied between 60 
and 90 minutes, whereas those following injection of the normal serum-vaccine 
mixture were only 30 minutes in 5 out of 7 animals and 45 minutes in the re- 
maining 2. In only 1, however, was the height and duration of fever increased, 
and in no instance was there a return of the second peak usually observed in 
non-refractory animals. In contrast to these results, injection of the same dose 
of vaccine incubated in the serum from tolerant donors produced no change in 
9 This term is used to apply to serum from animals which had received a course of pyrogen 
injections establishing tolerance. E.  ATKINS,  ?.  ALLISON,  fR.~ M'.  R.  SMITH~ W.  B.  WOOD, JR.  361 
the period of latency (Fig. 4). Lags in response of 75 to 90 minutes occurred in 
4 out of 5 instances and the temperature of the 5th animal never rose more than 
0.5°F. The febrile reaction of all 5 animals, once begun, did not differ signif- 
icantiy from those of the tolerant controls. Thus the observation of Grant (13) 
that the accelerating serum factor is present in normal but lacking or masked 
in refractory serum was confirmed. 
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TLXT-FIo.  6. Temperature responses of 4 cortisone-treated rabbits to intravenous inocu- 
lation on successive days with: (A) 15 million typhoid bacilli in pyrogen-free saline. (B)  15 
million typhoid bacilli incubated in normal homologous serum. 
Experiment D.--To test for a possible decrease of serum factor activity in the 
blood during cortisone therapy, 7 rabbits previously made tolerant by daily 
injections of vaccine were challenged with the same standard dose of typhoid 
vaccine incubated in the serum of cortisone-treated  donors.  The  results  as 
regards shortening of the latent period were found to be exactly the same as when 
the vaccine was incubated with normal (non-refractory) serum. A representa- 
tive response is shown in Fig. 5. The latent period was shortened from between 
60 and 90 minutes during tolerance to 30 minutes in 6 out of 7 rabbits and to 
45 minutes in the 7th. Again as with normal serum, there was no significant 
change noted in the height or duration of the fever. 
Experiment E.--The  possible  effect of serum factor upon  the  antipyretic 362  ANTIPYRETIC  ACTION  0]~  CORTISONE 
action of cortisone was also studied in 4 rabbits pretreated with a full course of 
the  drug.  Each  rabbit  was  challenged first with  15  million typhoid bacilli 
suspended in 5 ml. of pyrogen-free saline and on the next day was given the 
same dose previously incubated in either 5 or 10 ml. of normal serum. This 
amount of vaccine  (approximately 5  million bacilli per kg.)  had previously 
been shown to cause a brisk fever in normal controls. As indicated by Fig. 6 the 
fever was just as effectively  suppressed by cortisone on the day that the vaccine 
was incubated in serum as it was on the preceding day when the vaccine was 
suspended only in saline. 
The results of these experiments (D and E) indicate: (a) that cortisone, when 
given in amounts sufficient to cause a marked antipyretic effect, does not sig- 
nificantly alter the serum factor activity of the blood and (b)  that previous 
incubation of the pyrogen with serum factor fails to influence the antipyretic 
effect of the cortisone. It is concluded, therefore, that cortisone does not exert 
its antipyretic effect by acting upon serum factor. 
DISCUSSION 
Although fever is one of the most familiar manifestations of disease sur- 
prisingly little is  known  concerning  its  pathogenesis  (20,  41,  42).  Current 
knowledge of the subject is based primarily upon studies of experimental fever 
induced by the Intravenous injection of bacterial pyrogens (5). That the result- 
ing fever may involve mechanisms other than those that operate in febrile 
diseases of man is well recognized (43, 44). The pyrogen method was, neverthe- 
less, used in the present experiments for three reasons.  First, it provides a 
convenient laboratory model for investigating the action of an antipyretic; 
secondly, when given in  sufficient dosage,  l°  cortisone is known to  suppress 
pyrogen-induced fever  (1,  2);  and  thirdly,  knowledge  of  the  experimental 
febrile response is considerably greater than that of any other form of fever. 
The following points concerning pyrogen fever are pertinent to the present 
study. 
1. A sudden and often marked leucopenia involving primarily polymorpho- 
nuclear cells and eventually followed by leucocytosis, regularly precedes the 
onset of fever (5, 8). Its causal relationship to the fever is at present unproven. 
2.  Pyrogen previously incubated with normal serum causes an accelerated 
febrile response in normal recipients (8). The accelerated response is thought to 
result from the formation of a  pyrogen-serum factor complex which functions 
as a  fast acting pyrogen (10). 
3. The accelerating factor, present in normal serum, is not apparent in the 
10 Duffy and Morgan (45) have reported that pyrogen-induced fever may actually be en- 
hanced by relatively small doses of cortisone. The importance of dosage and time of adminis- 
tration in determining the effect of cortisone on pyrogen fever has also been emphasized by 
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blood of rabbits made pyrogen-tolerant by repeated daily injections (13, 46). 
Its absence, presumed to be due to removal or binding by the repeatedly in- 
jected pyrogen, has been offered as an explanation for the reduced responsive- 
ness of pyrogen-tolerant animals,  n 
The reasons for studying the effects of cortisone on the leucopenic response to 
injected pyrogen and for investigating the drug's possible action on the acceler- 
ating serum factor have already been discussed. It was suggested a priori that 
cortisone might exert its antipyretic effect either by blocking the leucopenic 
reaction which precedes the febrile response or by affecting the serum factor 
with which the injected substance is thought to combine. The results of the 
present experiments indicate that neither of these processes is involved. They 
suggest that cortisone acts upon a later and as yet undefined stage of the fever- 
producing mechanism. Whether the drug interferes with the release or activity 
of endogenous pyrogen, possibly derived from intravascular cells stimulated 
or injured by the injected pyrogen, or whether it merely depresses the respon- 
siveness of the central nervous system to the pyrogenic stimulus, remains to be 
determined. 
The regularity with which leucopenia precedes pyrogen fever, the extraction 
of a  pyrogenic substance from inflammatory exudates (44,  48-50),  and  the 
demonstration of an active pyrogen in polymorphonuclear leucocytes (51, 52), 
all suggest that the leucocytic reaction to the pyrogen may indeed be related 
to the fever produced (9).  There is evidence that the leucopenia is merely a 
reflection of sudden sequestration of leucocytes at a  variety of intravascular 
sites (27, 53).  In fact, a number of workers (28, 29) have observed by direct 
microscopy that, following the injection of certain pyrogens, leucocytes are 
immobilized in small vessels in which they appear  to  "stick"  to  the endo- 
thelium.  I~ It  is possible  that leucocytes thus immobilized may provide  the 
principal source of the endogenous pyrogen, which in turn may be responsible 
for the fever (9). 
In the present experiments cortisone has been shown to cause a  marked 
depression of pyrogen-induced fever without significantly influencing the leuc~ 
penic reaction. This dissociation of the febrile and leucopenic responses should 
not be interpreted to indicate that the two phenomena are necessarily  unrelated. 
On the contrary, it is still possible that the leucopenic reaction constitutes an 
important step in the pyrogenic process and that the cortisone, as already sug- 
gested, exerts its antipyrefic effect by influencing a later stage of the reaction. 
n As previously  noted, there is evidence that other factors may be involved in pyrogen 
tolerance, including  the development  of plasma inldbitors (ll) and an accelerated removal of 
pyrogen from the circulation by cells of the reticulo-endothelial  system (47). The relative 
importance of these various factors is at present a matter of controversy  (13). 
12 This "sticking" phenomenon  is $~milar to that observed during experimental  bacteriemia 
(30). Further evidence that circulating  leucocytes  are affected by injected pyrogen has re- 
cently been demonstrated by the in ¢i~ro studies of Berthrong and Cluff (54). 364  ANTIPYRETIC  ACTION  OF  CORTISONE 
From these considerations  it is obvious  that more definite  information is 
needed concerning the possible role of the leucopenic response  in the patho- 
genesis of pyrogen-induced fever. Demonstration that inflammatory  ceils serve 
as an important source of endogenous pyrogen in this form of  experimental 
fever would provide indirect evidence that similar cells may be involved in the 
fever of human disease (9). 
SUMMARY 
The mode of  action  of  cortisone  as  an antipyretic  has been studied  in rabbits 
challenged  with intravenous injections  of  bacterial  pyrogens. The fever  induced 
by pyromen or dextran was found to be markedly suppressed when cortisone 
was administered in liberal  amounts (25 rag.  twice  daily)  for 3 days prior  to 
the challenge.  Although the cortisone  effectively  blocked the febrile  response to 
both pyrogens, it  failed  to  influence  the transient  but marked leucopenia which 
characteristically  precedes the onset of fever. 
The antipyretic  action  of the drug also  was shown to  bear no relation  to the 
activity  of the serum factor  recently  demonstrated by Farr,  Grant, and others 
to be involved in the production of pyrogen-induced fever. In preliminary 
experiments  with typhoid vaccine as the inciting  pyrogen,  the presence of 
serum factor  activity  in normal blood and its  absence in the blood of  pyrogen- 
tolerant  rabbits  was confirmed.  Subsequently the blood of  rabbits  treated  with 
antipyretically  effective  doses of cortisone  was shown to contain just  as much 
serum factor  activity  as  that  of  normal rabbits.  In  addition,  previous  incubation 
of  the  pyrogen with serum factor  failed  to  influence  the antipyretic  effect  of  the 
drug. 
It is  concluded from these  findings  that in suppressing pyrogen fever,  corti- 
sone acts  neither  upon the leucopenic  reaction  nor upon the fever-accelerating 
factor  of the serum. By exclusion  it  would appear that  the drug must influence 
some later  stage  of the fever-producing process.  The mechanisms involved in 
the later  stages  of the response to exogenous pyrogen remain undefined, and 
the need for determining whether they are related  to the prefebrile  leucopenia 
is emphasized. 
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